267 related articles for article (PubMed ID: 29499331)
1. Systemic administration of scAAV9-IGF1 extends survival in SOD1
Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
[TBL] [Abstract][Full Text] [Related]
2. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
3. The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector.
Wen D; Cui C; Duan W; Wang W; Wang Y; Liu Y; Li Z; Li C
Brain Res Bull; 2019 Jan; 144():1-13. PubMed ID: 30414993
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1
Lin H; Hu H; Duan W; Liu Y; Tan G; Li Z; Liu Y; Deng B; Song X; Wang W; Wen D; Wang Y; Li C
Mol Neurobiol; 2018 Jan; 55(1):682-695. PubMed ID: 27995572
[TBL] [Abstract][Full Text] [Related]
5. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
[TBL] [Abstract][Full Text] [Related]
6. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
[TBL] [Abstract][Full Text] [Related]
7. Slow Intrathecal Injection of rAAVrh10 Enhances its Transduction of Spinal Cord and Therapeutic Efficacy in a Mutant SOD1 Model of ALS.
Li D; Liu C; Yang C; Wang D; Wu D; Qi Y; Su Q; Gao G; Xu Z; Guo Y
Neuroscience; 2017 Dec; 365():192-205. PubMed ID: 29024785
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death.
Dewil M; dela Cruz VF; Van Den Bosch L; Robberecht W
Neurobiol Dis; 2007 May; 26(2):332-41. PubMed ID: 17346981
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
10. Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS.
Veglianese P; Lo Coco D; Bao Cutrona M; Magnoni R; Pennacchini D; Pozzi B; Gowing G; Julien JP; Tortarolo M; Bendotti C
Mol Cell Neurosci; 2006 Feb; 31(2):218-31. PubMed ID: 16219474
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS.
Gibbs KL; Kalmar B; Rhymes ER; Fellows AD; Ahmed M; Whiting P; Davies CH; Greensmith L; Schiavo G
Cell Death Dis; 2018 May; 9(6):596. PubMed ID: 29789529
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
13. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
Ayers JI; Fromholt S; Sinyavskaya O; Siemienski Z; Rosario AM; Li A; Crosby KW; Cruz PE; DiNunno NM; Janus C; Ceballos-Diaz C; Borchelt DR; Golde TE; Chakrabarty P; Levites Y
Mol Ther; 2015 Jan; 23(1):53-62. PubMed ID: 25228069
[TBL] [Abstract][Full Text] [Related]
14. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
15. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal Injection of scAAV9-hIGF1 Prolongs the Survival of ALS Model Mice by Inhibiting the NF-kB Pathway.
Hu H; Lin H; Duan W; Cui C; Li Z; Liu Y; Wang W; Wen D; Wang Y; Li C
Neuroscience; 2018 Jun; 381():1-10. PubMed ID: 29447858
[TBL] [Abstract][Full Text] [Related]
17. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
Shan X; Vocadlo D; Krieger C
Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
[TBL] [Abstract][Full Text] [Related]
18. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
20. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
